Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
about
Trimetazidine for stable anginaRetained features of embryonic metabolism in the adult MRL mouseWITHDRAWN: Trimetazidine for stable angina.Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.Is treatment with trimetazidine beneficial in patients with chronic heart failure?Improvement of mechanical heart function by trimetazidine in db/db mice.Modulating fatty acid oxidation in heart failure.Myocardial ischemia reperfusion injury: from basic science to clinical bedside.Emerging drugs for acute and chronic heart failure: current and future developments.Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine.Metabolic modulation and cellular therapy of cardiac dysfunction and failure.Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus.Overview of emerging pharmacotherapy in chronic heart failure.Potential of metabolic agents as adjunct therapies in heart failure.Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.Metabolic remodelling in human heart failure.Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.Trimetazidine and cardioprotection: facts and perspectives.Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result.Myocardial metabolic manipulation: a new therapeutic approach in heart failure?Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.Meta-analysis of trimetazidine treatment for cardiomyopathy.Metabolic Modulation of Cardiac Metabolism in Heart Failure
P2860
Q24245946-FB6A226F-5AF6-4E65-9D8A-DE702B6970B7Q28306199-DA6A3E24-5E52-430B-9CC3-2D873BFD0057Q30400121-5B1781BD-FCDA-4328-91C7-FD0EA270186AQ30497085-BDDF600C-A039-4D47-B35B-ED99797F1329Q30585014-9D092393-40DF-424C-B006-7E1AC8D35600Q33567682-FE05FB55-D5A0-486A-A979-2FAC3937F904Q34193904-058BF9E6-0691-4164-B4B2-B9FF95FB2342Q34808505-F90BC81C-39A4-4DE3-8902-42F3206590E8Q36278316-0A3ECB2F-9E23-42DF-9F18-6A63E7665D82Q36758585-770D7E66-AF37-4D22-B6CE-3DA7C8823855Q37165686-7356FF25-9E2F-481D-895C-761FA1F54B7CQ37296154-41AAB830-1EA7-4EAC-B32C-FBBCE1393459Q37370870-3022B0F8-A373-4DC2-9DBE-A62B76BFE0C3Q37552943-A8FB0040-546C-4BAB-B3AC-02B58E4AD4B8Q37608595-2906C9C3-6372-49D5-A207-52ADC50B0199Q37785792-8BCE8E92-441F-41EC-988D-D2662772C544Q37849446-A4318D5C-7DF7-45DA-8EC9-5DAA44C564F8Q37871496-68790BF6-6BF7-410B-B1F0-EF9D992334C1Q38083574-D7E2AEA4-A228-4D6B-9910-ACE7154CF036Q38203492-74C8FBC0-F1FC-47AF-8FF6-960D745C84ADQ38217985-CD12F429-E18E-4C44-BBCE-651B780A09ECQ38371888-E9A7D0E2-3619-4E30-95D0-516AAF013F31Q38732082-E67AD7E0-3F96-4CB9-B6E3-230DBF72A967Q38920729-A55E9544-A4C5-4847-9ECC-B3F333E552D2Q39397055-F35A2994-4F08-4F69-BDD8-3B63476F92C5Q42837522-02797E8D-E4CF-4B20-9148-91E297191BFFQ43012953-C527C2EA-718C-4E10-970F-30201370C106Q46363288-DA25B480-BB1C-4B4D-BB81-3331A2B34211Q47117911-38DEE069-5113-45D4-8DAE-57BDA46789D2Q55071497-A45C4041-1136-4B94-AFE7-124F007387D8Q58804689-49C075DB-CFF1-4BC5-8F07-D5DE62DCE39D
P2860
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Trimetazidine improves left ve ...... blind placebo-controlled study
@nl
Trimetazidine improves left ve ...... lind placebo-controlled study.
@ast
Trimetazidine improves left ve ...... lind placebo-controlled study.
@en
type
label
Trimetazidine improves left ve ...... blind placebo-controlled study
@nl
Trimetazidine improves left ve ...... lind placebo-controlled study.
@ast
Trimetazidine improves left ve ...... lind placebo-controlled study.
@en
prefLabel
Trimetazidine improves left ve ...... blind placebo-controlled study
@nl
Trimetazidine improves left ve ...... lind placebo-controlled study.
@ast
Trimetazidine improves left ve ...... lind placebo-controlled study.
@en
P2093
P2860
P356
P1476
Trimetazidine improves left ve ...... blind placebo-controlled study
@en
P2093
Barbara Sposato
Cristiana Vitale
Giuseppe M C Rosano
Massimo Fini
P2860
P2888
P356
10.1186/1475-2840-2-16
P407
P577
2003-11-28T00:00:00Z
P5875
P6179
1020716633